CANCER
DEAD

Serial Number

85876328

Owner

Celgene Corporation

Attorney

Camille M. Miller

Filing Date

Mar 14, 2013

Add to watchlist:

No watchlists yet
View on USPTO

CANCER Trademark

Serial Number: 85876328

CANCER is a trademark filed by Celgene Corporation on March 14, 2013. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently no longer active.

Owner Contact Info

Celgene Corporation (883 trademarks)

7 Powder Horn Drive
Warren, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

March 14, 2013

Registration Date

Not Registered

Published for Opposition

June 11, 2013

Goods & Services

Pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of certain blood diseases and cancers

Government pharmaceutical programs that provide counseling and information to medical professionals, pharmacists and patients, including counseling and information on consumer product safety issues pertaining to pharmaceuticals, and distributing printed materials in connection therewith

Providing on-line information in the field of diagnosis and treatment of cancer; providing an on-line computer database featuring information relating to diagnosis and treatment of cancer; providing medical and pharmaceutical information services; providing links to web sites of others featuring information about the diagnosis and treatment of cancer; providing medical information and pharmaceutical information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; disease management programs that provide counseling and information in the field of pharmaceuticals, and distributing written materials in connection therewith; providing an interactive website featuring medical information that enables users to enter, access, track, monitor and generate health and medical information and reports; providing pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping, all for medical diagnostic and treatment purposes, based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries

Development and testing services in the fields of biotechnology, chemistry and pharmaceuticals; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services for medical and scientific research and development purposes, namely, pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific research services; scientific research, namely, development of pharmaceuticals or diagnostic methods for others

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Sep 12, 2016 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 12, 2016 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 22, 2016 EXRA
SOU EXTENSION 5 GRANTED
Jan 21, 2016 EX5G
SOU EXTENSION 5 FILED
Dec 29, 2015 EXT5
SOU TEAS EXTENSION RECEIVED
Dec 29, 2015 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 28, 2015 TCCA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 10, 2015 EXRA
SOU EXTENSION 4 GRANTED
Jul 9, 2015 EX4G
SOU EXTENSION 4 FILED
Jun 30, 2015 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 30, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 27, 2015 EXRA
SOU EXTENSION 3 GRANTED
Jan 26, 2015 EX3G
SOU EXTENSION 3 FILED
Jan 5, 2015 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 5, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 6, 2014 EXRA
SOU EXTENSION 2 GRANTED
Aug 5, 2014 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 5, 2014 AITU
SOU EXTENSION 2 FILED
Jul 8, 2014 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 8, 2014 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 9, 2014 EXRA
SOU EXTENSION 1 GRANTED
Jan 7, 2014 EX1G
SOU EXTENSION 1 FILED
Jan 7, 2014 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 7, 2014 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 6, 2013 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 11, 2013 NPUB
PUBLISHED FOR OPPOSITION
Jun 11, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 22, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 4, 2013 PREV
ASSIGNED TO LIE
May 4, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 24, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 24, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 24, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 24, 2013 TROA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Apr 24, 2013 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Apr 24, 2013 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Apr 24, 2013 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Apr 24, 2013 CPEA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Apr 23, 2013 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Apr 23, 2013 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Apr 23, 2013 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Apr 23, 2013 CPEA
ASSIGNED TO EXAMINER
Apr 17, 2013 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 21, 2013 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 20, 2013 NWOS
NEW APPLICATION ENTERED
Mar 18, 2013 NWAP